By “self-marking” endogenous double-stranded RNAs, ADAR1 prevents aberrant activation of cytosolic RNA sensors such as MDA5, thereby limiting tonic type I interferon signaling that would otherwise trigger tumor cell immunogenicity. Here, ADAR is linked to neoplasm.